根治性放化疗疗程中血清HSP70变化轨迹对子宫颈鳞癌患者预后的预测效能OA
The predictive efficacy of the serum HSP70 change trajectory during the radical radiotherapy and chemotherapy course for the prognosis of patients with cervical squamous cell carcinoma
目的 探讨根治性放化疗(CRT)疗程中血清热休克蛋白70(HSP70)变化轨迹对子宫颈鳞癌(CSCC)患者预后的预测效能.方法 选取2020年7月至2024年7月该院收治的203例拟进行CRT治疗的CSCC患者作为研究对象,于治疗前、1个疗程后、疗程结束时检测血清HSP70水平.采用潜类别轨迹模型(LCTM)分析CRT疗程血清HSP70变化轨迹并建立轨迹模型,Kaplan-Meier生存曲线分析比较不同轨迹组生存曲线,多因素COX回归分析CSCC患者预后的影响因素,采用风险预测模型评估指标分析CRT疗程血清HSP70变化轨迹预测CSCC患者预后价值.结果 所有对象治疗前、1个疗程后、疗程结束时血清HSP70水平分别为(101.25±28.47)ng/mL、(83.02±24.96)ng/mL、(67.66±15.20)ng/mL.LCTM 分析结果显示,潜在类别为3时模型最优,此时得到3个轨迹组.T1组[65例(32.02%)]CRT疗程血清HSP70水平从低水平快速降低,T2组[67例(33.00%)]CRT疗程血清HSP70从中低水平降低,T3组[71例(34.98%)]CRT疗程血清HSP70水平始终保持在高水平或降低不明显.T1组、T2组、T3组国际妇产科联盟(FIGO)分期比较,差异有统计学意义(P<0.05).随访过程中存在6例删失病例,Kaplan-Meier生存曲线分析结果显示,经Log-Rank x2检验,3个轨迹组生存曲线整体比较,差异有统计学意义(x2=48.305,P=0.001),T3组生存率为37.68%(26/69)低于T2组的78.46%(51/65)、T1组的92.06%(58/63),且T2组生存率低于T1组,差异均有统计学意义(P<0.05).多因素COX回归分析以T1组为参照,在校正FIGO分期后,T2组患者的死亡风险为T1组的2.006倍(P<0.001),T3组患者的死亡风险为T1组的3.355倍(P<0.001),线性趋势检验显示,T1组、T2组、T3组的死亡风险呈线性增加趋势,差异有统计学意义(P<0.05).风险预测模型评估显示,CRT疗程血清HSP70变化轨迹为T3时,预测死亡风险的灵敏度为69.35%,特异度为80.74%,阳性预测值为62.32%,阴性预测值为85.16%.结论 CRT疗程中血清HSP70的动态变化轨迹可有效预测CSCC患者的预后,其中持续高表达型患者死亡风险显著增加,这一发现为筛选能从CRT中生存获益潜在患者提供参考.
Objective To explore the predictive efficacy of the serum heat shock protein 70(HSP70)change trajectory during the radical radiotherapy and chemotherapy(CRT)course for the prognosis of pa-tients with cervical squamous cell carcinoma(CSCC).Methods A total of 203 patients with CSCC who were scheduled for CRT treatment in the hospital from July 2020 to July 2024 were selected as the research sub-jects.Serum HSP70 level was detected before treatment,1 treatment cycle later and at the end of the treat-ment cycle.The latent class trajectory model(LCTM)was used to analyze the serum HSP70 change trajecto-ry during the CRT course and establish a trajectory model.The Kaplan-Meier survival curve was used to com-pare the survival curves of different trajectory groups.Multivariate COX regression analysis was used to ana-lyze the influencing factors of the prognosis of CSCC patients.The risk prediction model assessment was used to evaluate the value of the serum HSP70 changes trajectory during the CRT course in predicting the progno-sis of CSCC patients.Results The serum HSP70 levels of all subjects before treatment,1 treatment cycle lat-er,and at the end of the treatment cycle were(101.25±28.47)ng/mL,(83.02±24.96)ng/mL and(67.66±15.20)ng/mL respectively.LCTM analysis showed that the optimal model was obtained when the number of potential classes was 3,and 3 trajectory groups were obtained at this time.In the T1 group,65 cases(32.02%)had a rapid decrease in serum HSP70 levels during the CRT course,in the T2 group,67 cases(33.00%)had a decrease from a medium-low level during the CRT course,and in the T3 group,71 cases(34.98%)maintained a high level of serum HSP70 or showed no significant decrease during the CRT course.There were statistically significant differences in international federation of gynecology and obstetrics(FIGO)stage among the T1,T2,and T3 groups(P<0.05).During the follow-up period,there were 6 censored cases.The Kaplan-Meier survival curve analysis showed that after Log-Rank x2 test,the overall comparison of the survival curves of the three groups was statistically significant(x2=48.305,P=0.001),and the survival rate of the T3 group[37.68%(26/69)]was lower than that of the T2 group[78.46%(51/65)]and the T1 group[92.06%(58/63)],and the survival rate of the T2 group was lower than that of the T1 group,and the differ-ences were statistically significant(P<0.05).Multivariate COX regression analysis with the T1 group as the reference showed that the death risk of patients in the T2 group was 2.006 times that of the T1 group after adjusting for FIGO stage(P<0.001),and the death risk of patients in the T3 group was 3.355 times that of the T1 group(P<0.001).Linear trend test showed that the death risk of the T1 group,T2 group and T3 group increased linearly,and the difference was statistically significant(P<0.05).Risk prediction model as-sessment showed that when the serum HSP70 changes during the CRT course were at T3,the sensitivity for predicting the death risk was 69.35%,the specificity was 80.74%,the positive predictive value was 62.32%,and the negative predictive value was 85.16%.Conclusion The dynamic changes trajectory of serum HSP70 during the CRT course can effectively predict the prognosis of CSCC patients.Patients with continuous high expression of serum HSP70 have a significantly increased risk of death.This finding provides a reference for screening potential patients who can benefit from CRT.
王云涛;何朗;徐毅;熊伟杰
成都市第五人民医院肿瘤科,四川成都 611130成都市第五人民医院肿瘤科,四川成都 611130成都市第五人民医院肿瘤科,四川成都 611130成都市第五人民医院肿瘤科,四川成都 611130
医药卫生
根治性放化疗热休克蛋白70变化轨迹子宫颈鳞癌预后预测效能
radical radiotherapy and chemotherapyheat shock protein 70change trajectorycervi-cal squamous cell carcinomaprognosispredictive efficacy
《检验医学与临床》 2026 (9)
1209-1215,7
四川省卫生健康科研课题(23PJ167).
评论